Cardiff Oncology (CRDF) EPS (Basic) (2011 - 2026)
Cardiff Oncology (CRDF) posted EPS (Basic) of -$0.11 for Q4 2025, up 35.84% sequentially from -$0.17 in Q3 2025, and up 56.34% YoY from -$0.07 in Q4 2024.
Cardiff Oncology (CRDF) EPS (Basic) (2011 - 2026) Analysis & Trends
Cardiff Oncology has reported EPS (Basic) for 15 years, with the latest figure at -$0.11 in Q4 2025.
- Quarterly EPS (Basic) rose 56.34% year-over-year to -$0.11 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.69 (up 28.05% YoY) and the FY2025 annual result came in at -$0.69, up 28.05% from the prior year.
- EPS (Basic) rose to -$0.11 in Q4 2025 per CRDF's latest filing, from -$0.17 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.11 in Q4 2025 and troughed at -$0.26 in Q2 2024.
- A 5-year average of -$0.21 and a median of -$0.21 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2021 and 2022: EPS (Basic) soared 66.24% in 2021, then slumped 82.36% in 2022.
- Over 5 years, EPS (Basic) stood at -$0.24 in 2021, then grew by 17.54% to -$0.2 in 2022, then slipped by 4.77% to -$0.21 in 2023, then fell by 18.35% to -$0.25 in 2024, then surged by 56.34% to -$0.11 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.11, -$0.17, and -$0.21 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Cardiff Oncology | 60.21 Mn | 60.21 Mn | - | -0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.14 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -0.21 |
| Mar 31, 2025 | -0.20 |
| Dec 31, 2024 | -0.25 |
| Sep 30, 2024 | -0.25 |
| Jun 30, 2024 | -0.26 |
| Mar 31, 2024 | -0.22 |
| Dec 31, 2023 | -0.21 |
| Sep 30, 2023 | -0.22 |
| Jun 30, 2023 | -0.25 |
| Mar 31, 2023 | -0.25 |
| Dec 31, 2022 | -0.20 |
| Sep 30, 2022 | -0.20 |
| Jun 30, 2022 | -0.24 |
| Mar 31, 2022 | -0.25 |
| Dec 31, 2021 | -0.24 |
| Sep 30, 2021 | -0.17 |
| Jun 30, 2021 | -0.17 |